Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Campus
Campus

Gaucher

Were You Expecting Leukaemia?

Think Gaucher Disease

A Diagnostic Algorithm for Adults1

Understanding Gaucher Disease Type 1

GD is the most common LSD caused by a deficiency in glucocerebrosidase enzyme. GD patients may experience 10 years of diagnostic delay.

Test for diagnosis

  • Enzyme activity test on DBS
  • Whole blood sample analysis to confirm diagnosis

References

  1. Mistry PK, et al. Am J Hematol. 2011. 86(1):110–115.
  2. Mehta A. Eur J Intern Med. 2006;17 Suppl: S2–S5. REFERENCES
  3. Hannah-Shmouni F, et al. Mol Genet Metab Rep. 2019;18:19–21.

One JLT Building, Level 3, Jumeirah Lake Towers, PO Box 53899, Dubai, UAE For further medical information, please contact: For UAE 800 MEDICAL Toll Free Number. For all Gulf countries +971 565776791 or email: medical-information.gulf@sanofi.com.

Full prescribing information is available upon request.
To Report adverse events please call: +971 561747001 or email Gulf.Pharmacovigilance@sanofi.com
www.sanofi.com
To report any side effect(s): Saudi Arabia: The National Pharmacovigilance and Drug Safety Centre (NPC): SFDA call center: 19999 • E-mail: npc.drug@sfda.gov.sa • Website: https://ade.sfda.gov.sa/

Full Prescribing Information is available upon request:
SANOFI, Kingdom of Saudi Arabia, P.O. Box 9874, Jeddah 21423, K.S.A. Tel: +966-12-669-3318, Fax: +966-12-663-6191
For Medical Information, Please contact: +966-12-669-3318, ksa.medicalinformation@sanofi.com
For Pharmacovigilance, Please contact: +966-54-428-4797, ksa_pharmacovigilance@sanofi.com

To report any Product Technical Complaint, please contact SANOFI Quality Department:
Email: quality.greatergulf@Sanofi.com
www.sanofi.com.sa

MAT-BH-2300001-V1 April 23

Were You Expecting Leukaemia?

Think Gaucher Disease

A Diagnostic Algorithm for Paediatric Patients1

Understanding Gaucher Disease Type 1

GD is the most common LSD caused by a deficiency in glucocerebrosidase enzyme. GD patients may experience 10 years of diagnostic delay.

Test for diagnosis

  • Enzyme activity test on DBS
  • Whole blood sample analysis to confirm diagnosis

References

  1. Di Rocco M, et al. Pediatric Blood Cancer 2014. 61(11):1905–1909.
  2. Mehta A. Eur J Intern Med. 2006;17 Suppl: S2–S5.
  3. Hannah-Shmouni F, et al. Mol Genet Metab Rep. 2019;18:19–21.

One JLT Building, Level 3, Jumeirah Lake Towers, PO Box 53899, Dubai, UAE For further medical information, please contact: For UAE 800 MEDICAL Toll Free Number. For all Gulf countries +971 565776791 or email: medical-information.gulf@sanofi.com.

Full prescribing information is available upon request.
To Report adverse events please call: +971 561747001 or email Gulf.Pharmacovigilance@sanofi.com
www.sanofi.com
To report any side effect(s): Saudi Arabia: The National Pharmacovigilance and Drug Safety Centre (NPC): SFDA call center: 19999 • E-mail: npc.drug@sfda.gov.sa • Website: https://ade.sfda.gov.sa/

Full Prescribing Information is available upon request:
SANOFI, Kingdom of Saudi Arabia, P.O. Box 9874, Jeddah 21423, K.S.A. Tel: +966-12-669-3318, Fax: +966-12-663-6191
For Medical Information, Please contact: +966-12-669-3318, ksa.medicalinformation@sanofi.com
For Pharmacovigilance, Please contact: +966-54-428-4797, ksa_pharmacovigilance@sanofi.com

To report any Product Technical Complaint, please contact SANOFI Quality Department:
Email: quality.greatergulf@Sanofi.com
www.sanofi.com.sa

MAT-BH-2300002-V1 April 23